MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with R

Riluzole

Riluzole 50mg orodispersible films

No stability information

Stability notes for Riluzole 50mg orodispersible films

There are no stability notes for this medicine.

Supplier

Emylif 50mg orodispersible films (Zambon UK Ltd)

Riluzole 50mg tablets

Use with caution

Stability notes for Riluzole 50mg tablets

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products riluzole 50mg tablets (Glenmark Pharmaceuticals Europe Ltd) and riluzole 50mg tablets (Ranbaxy (UK) Limited).

Suppliers (7) of Riluzole 50mg tablets
Riluzole 50mg tablets (A A H Pharmaceuticals Ltd)
Riluzole 50mg tablets (Accord-UK Ltd)
Riluzole 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Riluzole 50mg tablets (Medihealth (Northern) Ltd)
Riluzole 50mg tablets (Pilsco Ltd)
Riluzole 50mg tablets (Sigma Pharmaceuticals Plc)
Riluzole 50mg tablets (Sun Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.